G3BP1 and TIA-1 double-KD cells, which had decreased MuV-induced SGs, partly increased MuV-induced IFN-λ1 production, but did not affect MuV replication. by Shin Hashimoto (3079659)

Decrease of cell viability and alterations of cell membrane permeability by infection with rotavirus isolates. by Carlos A. Guerrero (1264551)

Fig 5 - by Torsten Schober (20485754)

Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey by Rujipat Wasitthankasem (732723)

Metformin pre-treatment retains an antioxidant effect and decreases apoptosis, in an AMPK activation manner. by Silvia Siteni (10344070)

Simulated effects of increased pCREB combined with decreased pCaMKIIα on time courses of molecular pathways and synaptic weight W after IA training. by Yili Zhang (540283)

“…The light blue area represents W less than 200% of basal level. (B) Example of dynamics of BDNF protein/mRNA (B1-2), C/EBPβ protein (B3), pCREB (B4), pCaMKIIα (B5), Sin3a binding (B6), MeCP2 binding (B7), HDAC2 binding (B8), and W (B9), with the standard parameter values in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1010239#pcbi.1010239.t001" target="_blank">Table 1</a> (black dashed) or with <i>k</i>_{<i>basalp_creb</i>} increased by ~50% and <i>k</i>_{<i>basalp_CaMKII</i>} decreased by ~50% from control combined with higher binding levels of MeCP2, Sin3a and HDAC2 (blue) to simulate IA conditioning in infant rats. …”

Corticosterone treatment decreases MMP-2 promoter activity. by Eric A. Shikatani (131260)

“…MMP-2 mRNA levels were decreased with corticosterone treatment (A) (p = 0.006, n = 5). …”

Multivariable longitudinal analysis of short, mid and long-term prognostic factors for decreased health status as measured with the EQ-5D-3L. by Nena Kruithof (8741346)

Fig 5 - by Elizabeth Garcia (23115)

Down-regulation of PDCD4 attenuates the ability of resveratrol to decrease viability and invasiveness of PC-3M-MM2 cells. by Sandeep Sheth (112040)

Relative decreases in VP mean weights using -DDE against TP controls in nine laboratories (Lab) by William Owens (20777)

Pretreatment with terazosin (0.5, 1 mg/kg) reversed the decrease in EEG amplitude produced by modafinil (90 mg/kg, i.p.). by Chang-Rui Chen (467755)

“…The increase in EEG amplitude may be interpreted as synchronization and a decrease in EEG can be interpreted as a desynchronization. …”

Fig 3 - by Calvin P. Philp (12095878)

Relative decreases in VP mean weights using VIN against TP controls in eight laboratories (Lab) by William Owens (20777)

Telmisartan decreased NO production in LPS-stimulated BV2 and primary neonatal rat glial cells. by Nofar Torika (3169497)

Decreased capillary density and cardiac fibrosis in <i>Nkx2.5-Cre/Foxm1^fl/fl</i> heart. by Craig Bolte (299486)

“…Capillary density was decreased in <i>Nkx2.5-Cre/Foxm1^fl/fl</i> hearts at P11 (A–B, I), while coronary vessel formation was not altered (C–D). …”

<i>dSmad2</i> mutant clones display increased dILP2 in IPCs and decreased dILP5 in CPCs. by Samuel L. Goldsmith (5533913)

SPL treatment decreases diabetes-induced decrement in protein expression of cldn-5 in glomeruli (GL) and cldn-2 and occldn in proximal tubules (PT). by Eduardo Molina-Jijón (4020464)

“…<p>SPL prevents diabetes-induced decrease of cldn-5 protein expression (A and B) in GL, and mRNA (F) and protein expression of cldn-2 (A and C), and protein expression of occldn (A and D) in PT (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s002" target="_blank">S2 Fig</a>). …”

Intranasal administration of telmisartan decreases amyloid plaques and CD11b staining in the cortex and hippocampus of 4-month old 5XFAD mice. by Nofar Torika (3169497)

Increased acetylated ATG proteins and decreased ATG5-ATG12 conjugation in the livers of L-<i>G6pc</i>-/- mice. by Jun-Ho Cho (4053676)